Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2013-000124-34-AT
EUCTR2013-000124-34-AT
Active, not recruiting
Not Applicable

Circulating Tumor cells in urothelial cancer patients relapsing after or refractory to platinum based first line chemotherapy

PD Dr. Maria De Santis0 sitesMarch 1, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCirculating tumor cells in urothelial cancer patients relapsing after or refractory to platinum based first line chemotherapyTherapeutic area: Diseases [C] - Cancer [C04]

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Circulating tumor cells in urothelial cancer patients relapsing after or refractory to platinum based first line chemotherapy
Sponsor
PD Dr. Maria De Santis
Status
Active, not recruiting
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2013
End Date
TBD
Last Updated
10 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
PD Dr. Maria De Santis

Eligibility Criteria

Inclusion Criteria

  • •\- Written informed consent
  • •\- Male or female patient with urothelial cancer aged \= 18 years
  • •\- Patient progressing during or after platinum containing combination chemotherapy or within 12 months after platinum containing chemotherapy in the perioperative setting
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 35
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 35

Exclusion Criteria

  • •Patient of childbearing potential (female patients only)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Circulating tumour cells in bladder cancer patients treated with chemotherapy and radical cystectomy – enumeration, characterization and evaluation of prognostic value (the CIRCH-study)rothelial carcinomaCancer
ISRCTN72499664und University182
Not yet recruiting
Not Applicable
Generation of urothelial cancer organoids to investigate tumor biology in organoids and to perform drug sensitivity testing.bladder cancerUrothelial cancer1003836410004994
NL-OMON52018Erasmus MC, Universitair Medisch Centrum Rotterdam117
Completed
Not Applicable
Relevance of circulating tumour cells in patients undergoing laparoscopic colon resection versus open resection: a randomised trialColorectal cancerCancerMalignant neoplasm of the colorectal area
ISRCTN28212149Academic Medical Centre (AMC) (Netherlands)30
Not yet recruiting
Not Applicable
Propagation of organoids from urology tumorsrothelial carcinoma, renal cancer, prostata cancer, penile cancerC60C61C64C65C66C67C68Malignant neoplasm of penisMalignant neoplasm of prostateMalignant neoplasm of kidney, except renal pelvisMalignant neoplasm of renal pelvisMalignant neoplasm of ureterMalignant neoplasm of bladderMalignant neoplasm of other and unspecified urinary organs
DRKS00030035niversitätsklinikum Ulm, Klinik für Urologie und Kinderurologie100
Completed
Not Applicable
Circulating tumour cells by diagnostic leukapheresis mirror primary tumour heterogeneity in non-small cell lung cancerlung cancerlung carcinomanon small cell lungcarcinomaNSCLC10038666
NL-OMON43511niversitair Medisch Centrum Groningen80